Motley Fool Money cover image

A New Name in Weight-Loss Drugs

Motley Fool Money

Exploring a New Weight-Loss Drug and the Business Model of Hymns and Hers

4min Snip

00:00
Play full episode
Exploring Hymns and Hers' innovative weight-loss drug, which offers a cost-effective alternative to brand name medications through strategic partnerships. The discussion highlights the implications of their telehealth and personalized medicine strategies on the healthcare industry.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode